DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Diltiazem Hydrochloride In Dextrose 5%, and when can generic versions of Diltiazem Hydrochloride In Dextrose 5% launch?
Diltiazem Hydrochloride In Dextrose 5% is a drug marketed by Exela Pharma and is included in one NDA.
The generic ingredient in DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5% is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diltiazem Hydrochloride In Dextrose 5%
A generic version of DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5% was approved as diltiazem hydrochloride by TEVA on May 31st, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5%?
- What are the global sales for DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5%?
- What is Average Wholesale Price for DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5%?
Summary for DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 106 |
| DailyMed Link: | DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5% at DailyMed |
Recent Clinical Trials for DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5%
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ascension Genesys Hospital | Phase 2 |
| Aurora Health Care | Phase 4 |
| Signia Therapeutics | Phase 2 |
See all DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5% clinical trials
Pharmacology for DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5%
| Drug Class | Calcium Channel Blocker |
| Mechanism of Action | Calcium Channel Antagonists |
US Patents and Regulatory Information for DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exela Pharma | DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5% | diltiazem hydrochloride | SOLUTION;INTRAVENOUS | 215252-001 | Oct 28, 2021 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Exela Pharma | DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5% | diltiazem hydrochloride | SOLUTION;INTRAVENOUS | 215252-002 | Oct 28, 2021 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
